Early-life estrogens and prostate cancer in an animal model

Journal of Developmental Origins of Health and Disease

Volumn 1, Issue 6, 2010, Pages 365-370

  Prins, G S ^a   Ho, S M ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

bisphenol A; estrogen; estrogenization; prostate development; reprogramming

Indexed keywords

EID: 79956135418     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174410000577     Document Type: Review

References (27)

1. Prins, GS, Putz, O. Molecular signaling pathways that regulate prostate gland development. Differentiation. 2008; 6, 641–659.
2. Ekbom, A, Hsieh, CC, Lipworth, L, et-al. Perinatal characteristics in relation to incidence of and mortality from prostate cancer. Br Med J. 1996; 313, 337–341.
3. Driscoll, SG, Taylor, SH. Effects of prenatal maternal estrogen on the male urogenital system. Obstet Gynecol. 1980; 56, 537–542.
4. Arai, Y, Chen, CY, Nishizuka, Y. Cancer development in male reproductive tract in rats given diethylstilbestrol at neonatal age. Gann. 1978; 69, 861–862.
5. Prins, GS. Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression. Endocrinology. 1992; 130, 3703–3714.
6. Prins, GS, Birch, L, Habermann, H, et-al. Influence of neonatal estrogens on rat prostate development. Reprod Fertil Dev. 2001; 13, 241–252.
7. Prins, GS, Huang, L, Birch, L, Pu, Y. The role of estrogens in normal and abnormal development of the prostate gland. Annals of the New York Academy of Sciences. 2006; 1089, 1–13.
8. Prins, GS. Developmental estrogenization of the prostate gland. In Prostate: Basic and Clinical Aspects (ed. Naz RK), 1997: Chapter 10; pp. 247–265. C. R. C. Press, Boca Raton.
9. Putz, O, Schwartz, CB, Kim, S, LeBlanc, GA, Cooper, RL, Prins, GS. Neonatal low- and high-dose exposure to estradiol benzoate in the male rat: I. Effects on the prostate gland. Biol Reprod. 2001; 65, 1496–1505.
10. Bosland, MC. Chemical and hormonal induction of prostate cancer in animal models. Urol Oncol. 1996; 2, 103–110.
11. Ho, SM, Tang, WY, Belmonte, J, Prins, GS. Developmental exposure estradiol and bisphenol A (BPA) increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant (PDE4D4) in the rat prostate. Cancer Res. 2006; 66, 5624–5632.
12. Prins, GS, Ye, SH, Birch, L, Ho, SM, Kannan, K. Serum Bisphenol A pharmacokinetics and prostatic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats. Repro Toxicology. 2010; online Oct 6.
13. Prins, GS, Birch, L. Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology. 1997; 138, 1801–1809.
14. Prins, GS, Marmer, M, Woodham, C, et-al. Estrogen receptor-b messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology. 1998; 139, 874–883.
15. Prins, GS, Birch, L, Couse, JF, Choi, I, Katzenellenbogen, B, Korach, KS. Estrogen imprinting of the developing prostate gland in mediated through stromal estrogen receptor a: studies with aERKO and bERKO mice. Cancer Res. 2001; 61, 6089–6097.
16. Pu, Y, Huang, L, Prins, GS. Sonic Hedgehog-patched-Gli signaling in the developing rat prostate gland: lobe-specific suppression by neonatal estrogens reduces ductal growth and branching. Dev Biol. 2004; 273, 257–275.
17. Timms, BG, Howdeshell, KL, Barton, L, Bradley, S, Richter, CA, vom Saal, FS. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. PNAS. 2005; 102, 7014–7019.
18. Chang, WY, Wilson, MJ, Birch, L, Prins, GS. Neonatal estrogen stimulates proliferation of periductal fibroblasts and alters the extracellular matrix composition in the rat prostate. Endocrinology. 1999; 140, 405–415.
19. Putz, O, Schwartz, CB, LeBlanc, GA, Cooper, RL, Prins, GS. Neonatal low- and high-dose exposure to estradiol benzoate in the male rat: II. Effects on male puberty and the reproductive tract. Biol Reprod. 2001; 65, 1506–1517.
20. Prins, GS, Woodham, C, Lepinske, M, Birch, L. Effects of neonatal estrogen exposure on prostatic secretory genes and their correlation with androgen receptor expression in the separate prostate lobes of the adult rat. Endocrinology. 1993; 132, 2387–2398.
21. Gilleran, JP, Putz, O, De Jong, M, et-al. The role of prolactin in the prostatic inflammatory response to neonatal estrogen. Endocrinology. 2003; 144, 2046–2054.
22. Woodham, C, Birch, L, Prins, GS. Neonatal estrogens down regulate prostatic androgen receptor levels through a proteosome-mediated protein degradation pathway. Endocrinology. 2003; 144, 4841–4850.
23. Huang, L, Pu, Y, Alam, S, Birch, L, Prins, GS. Estrogenic regulation of signaling pathways and homeobox genes during rat prostate development. J Androl. 2004; 25, 330–337.
24. Huang, L, Pu, Y, Birch, L, Prins, GS. Posterior Hox gene expression and differential androgen regulation in the developing and adult rat prostate lobes. Endocrinology. 2007; 148, 1235–1245.
25. Huang, L, Pu, Y, Hu, WY, et-al. The role of Wnt5a in prostate gland development. Dev Biol. 2009; 358, 188–199.
26. Huang, L, Pu, Y, Alam, S, Birch, L, Prins, GS. The role of Fgf10 signaling in branching morphogenesis and gene expression in the rat prostate gland: lobe-specific supression by neonatal estrogens. Dev Biol. 2005; 278, 396–414.
27. Prins, GS, Birch, L, Tang, WY, Ho, SM. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol. 2007; 23, 374–382.